Literature DB >> 4147835

Beta-adrenoceptor blocking agents. 1. Cardioselective 1-aryloxy-3-(aryloxyalkylamino)propan-2-ols.

J Augstein, D A Cox, A L Ham, P R Leeming, M Snarey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4147835     DOI： 10.1021/jm00269a007

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  6 in total

1.  Pharmacokinetic and pharmacological studies with tolamolol in man.

Authors:  J K Faulkner; D A Stopher; R Walden
Journal:  Br J Clin Pharmacol       Date:  1975-10       Impact factor: 4.335

2.  Clinical trial of a new beta-receptor blocking agent, tolamolol, in angina pectoris.

Authors:  I Nordenfelt; L Olsson; S Persson
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

3.  Dose-titrated, double-blind, cross-over comparison of a selective beta-blocker and methyldopa in the treatment of hypertension.

Authors:  P A Routledge; L V Zrinzo; J G Rao; R J Walden; D M Davies; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

4.  Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris.

Authors:  G Jackson; L Atkinson; S Oram
Journal:  Br Med J       Date:  1975-03-29

5.  Pharmacokinetics of tolamolol in the treatment of hypertension.

Authors:  P A Routledge; D M Davies; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

6.  Bioavailability of tolamolol.

Authors:  J K Faulkner; D A Stopher; R Walden; W Singleton; S H Taylor
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.